Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Shawer, HM"'
Autor:
Maqbool, A, Watt, N, Haywood, N, Viswambharan, H, Skromna, A, Makava, N, Visnagri, A, Shawer, HM, Bridge, K, Muminov, SK, Griffin, K, Beech, DJ, Wheatcroft, SB, Porter, KE, Simmons, KJ, Sukumar, P, Shah, AM, Cubbon, RM, Kearney, MT, Yuldasheva, NY
Insulin resistance leads to excessive endothelial cell (EC) superoxide generation and accelerated atherosclerosis. The principal source of superoxide from the insulin-resistant endothelium is the Nox2 isoform of NADPH oxidase. Here we examine the the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::46075043e9cc4f8e95f89247d9a8e50b
Autor:
Maqbool A; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Watt NT; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Haywood N; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Viswambharan H; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Skromna A; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Makava N; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Visnagri A; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Shawer HM; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Bridge K; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Muminov SK; Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan., Griffin K; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Beech DJ; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Wheatcroft SB; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Porter KE; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Simmons KJ; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Sukumar P; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Shah AM; British Heart Foundation, Centre of Research Excellence, King's College London, London, United Kingdom., Cubbon RM; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Kearney MT; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom., Yuldasheva NY; Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
Publikováno v:
American journal of physiology. Cell physiology [Am J Physiol Cell Physiol] 2020 Jul 01; Vol. 319 (1), pp. C64-C74. Date of Electronic Publication: 2020 May 13.
Autor:
Bartoli F; Inserm, UMR-S 1180, Signalisation et Physiopathologie Cardiovasculaire, Université Paris-Saclay, Châtenay-Malabry, France (F.B., P.M., K.B., P.G., S.G., F.L., A.-M.G., J.P.B., J. Sabourin)., Bailey MA; Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, United Kingdom (M.A.B., B.R., J.F.X.A., M.T.K., A.-F.B., J. Shi, H.L.A., R.S.Y., H.M.S., M.D., D.J.B.)., Rode B; Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, United Kingdom (M.A.B., B.R., J.F.X.A., M.T.K., A.-F.B., J. Shi, H.L.A., R.S.Y., H.M.S., M.D., D.J.B.)., Mateo P; Inserm, UMR-S 1180, Signalisation et Physiopathologie Cardiovasculaire, Université Paris-Saclay, Châtenay-Malabry, France (F.B., P.M., K.B., P.G., S.G., F.L., A.-M.G., J.P.B., J. Sabourin)., Antigny F; Inserm, UMR-S 999, Université Paris-Saclay, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France (F.A., C.R.M.)., Bedouet K; Inserm, UMR-S 1180, Signalisation et Physiopathologie Cardiovasculaire, Université Paris-Saclay, Châtenay-Malabry, France (F.B., P.M., K.B., P.G., S.G., F.L., A.-M.G., J.P.B., J. Sabourin)., Gerbaud P; Inserm, UMR-S 1180, Signalisation et Physiopathologie Cardiovasculaire, Université Paris-Saclay, Châtenay-Malabry, France (F.B., P.M., K.B., P.G., S.G., F.L., A.-M.G., J.P.B., J. Sabourin)., Gosain R; School of Chemistry, University of Leeds, United Kingdom (R.G., J.P., K.N., R.F.)., Plante J; School of Chemistry, University of Leeds, United Kingdom (R.G., J.P., K.N., R.F.)., Norman K; School of Chemistry, University of Leeds, United Kingdom (R.G., J.P., K.N., R.F.)., Gomez S; Inserm, UMR-S 1180, Signalisation et Physiopathologie Cardiovasculaire, Université Paris-Saclay, Châtenay-Malabry, France (F.B., P.M., K.B., P.G., S.G., F.L., A.-M.G., J.P.B., J. Sabourin)., Lefebvre F; Inserm, UMR-S 1180, Signalisation et Physiopathologie Cardiovasculaire, Université Paris-Saclay, Châtenay-Malabry, France (F.B., P.M., K.B., P.G., S.G., F.L., A.-M.G., J.P.B., J. Sabourin)., Rucker-Martin C; Inserm, UMR-S 999, Université Paris-Saclay, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France (F.A., C.R.M.)., Ainscough JFX; Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, United Kingdom (M.A.B., B.R., J.F.X.A., M.T.K., A.-F.B., J. Shi, H.L.A., R.S.Y., H.M.S., M.D., D.J.B.)., Kearney MT; Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, United Kingdom (M.A.B., B.R., J.F.X.A., M.T.K., A.-F.B., J. Shi, H.L.A., R.S.Y., H.M.S., M.D., D.J.B.)., Bruns AF; Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, United Kingdom (M.A.B., B.R., J.F.X.A., M.T.K., A.-F.B., J. Shi, H.L.A., R.S.Y., H.M.S., M.D., D.J.B.)., Shi J; Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, United Kingdom (M.A.B., B.R., J.F.X.A., M.T.K., A.-F.B., J. Shi, H.L.A., R.S.Y., H.M.S., M.D., D.J.B.)., Appleby HL; Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, United Kingdom (M.A.B., B.R., J.F.X.A., M.T.K., A.-F.B., J. Shi, H.L.A., R.S.Y., H.M.S., M.D., D.J.B.)., Young RS; Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, United Kingdom (M.A.B., B.R., J.F.X.A., M.T.K., A.-F.B., J. Shi, H.L.A., R.S.Y., H.M.S., M.D., D.J.B.)., Shawer HM; Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, United Kingdom (M.A.B., B.R., J.F.X.A., M.T.K., A.-F.B., J. Shi, H.L.A., R.S.Y., H.M.S., M.D., D.J.B.)., Debant M; Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, United Kingdom (M.A.B., B.R., J.F.X.A., M.T.K., A.-F.B., J. Shi, H.L.A., R.S.Y., H.M.S., M.D., D.J.B.)., Gomez AM; Inserm, UMR-S 1180, Signalisation et Physiopathologie Cardiovasculaire, Université Paris-Saclay, Châtenay-Malabry, France (F.B., P.M., K.B., P.G., S.G., F.L., A.-M.G., J.P.B., J. Sabourin)., Beech DJ; Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, United Kingdom (M.A.B., B.R., J.F.X.A., M.T.K., A.-F.B., J. Shi, H.L.A., R.S.Y., H.M.S., M.D., D.J.B.)., Foster R; School of Chemistry, University of Leeds, United Kingdom (R.G., J.P., K.N., R.F.)., Benitah JP; Inserm, UMR-S 1180, Signalisation et Physiopathologie Cardiovasculaire, Université Paris-Saclay, Châtenay-Malabry, France (F.B., P.M., K.B., P.G., S.G., F.L., A.-M.G., J.P.B., J. Sabourin)., Sabourin J; Inserm, UMR-S 1180, Signalisation et Physiopathologie Cardiovasculaire, Université Paris-Saclay, Châtenay-Malabry, France (F.B., P.M., K.B., P.G., S.G., F.L., A.-M.G., J.P.B., J. Sabourin).
Publikováno v:
Circulation [Circulation] 2020 Jan 21; Vol. 141 (3), pp. 199-216. Date of Electronic Publication: 2020 Jan 07.